Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain
About this study
The goal of this randomized control clinical trial is to learn if virtual reality can be used to treat sickle cell pain in children. The main questions it aims to answer are: Does virtual reality reduce pain severity during a child's hospital stay for a vaso-occlusive pain crisis? Does virtual reality decrease the daily use of opiates? Researchers will compare standard therapy to the use of standard therapy plus a daily virtual reality experience to see if virtual reality works to treat sickle cell pain. All patients will: \- Be asked to fill out a pain assessment survey three times daily for up to 3 days If randomized to intervention arm, patients will: * Participate in an immersive virtual reality experience once daily for up to 3 days * Fill out a survey twice daily to monitor for side effects from virtual reality experience * Fill out a satisfaction survey once during the study period
- Condition
- Sickle Cell Disease, Vaso-occlusive Pain Episodes
- Tested
- KindVR Aqua Program
- Sponsor
- Louisiana State University Health Sciences Center in New Orleans
Who can join
- Age
- 8 to 21 years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 7
- Minimum age: 8 years
- Maximum age: 21 years
- Study condition: Sickle Cell Disease, Vaso-occlusive Pain Episodes
- Patient ≥ 8 up to 21 years of age
- Presenting to CHNOLA ER or outside facility with chief complaint of vaso-occlusive pain crisis, requiring inpatient admission for further pain management
- No known cognitive or neurological deficits
- Parental/guardian permission (informed consent) and if appropriate, child assent.
Exclusion 6
- Patients aged 7-years-old and younger.
- Patents upon admission found to have sequela of their sickle cell disease that would require medical therapy greater than the standard of care for a vaso-occlusive pain event. This includes acute chest syndrome, splenic sequestration, post-operative pain, and/or cerebrovascular accident
- Patients who are developmentally or cognitively incapable of using VR equipment and answering questions appropriately
- Failure to obtain or refusal to provide parental/guardian permission (informed consent) and if appropriate child assent
- Patient has previously participated in the study
- Study team is unable to initiate study interventions within the first 24 hours of a patient's admission
Where
1 site, 1 recruiting
Children's Hospital of New Orleans
New Orleans, Louisiana, United States
Contact
-
Molly E Sonenklar, MD
504-896-9740 msonen@lsuhsc.edu
-
Casey M Treuting, MD
504-273-3476 ctreu1@lsuhsc.edu
Potential match only. Final eligibility is determined by the study team.